Home » Departments » Men's Health Update
Men’s Health Update
A survey of men with prostate cancer sought to identify when these patients were most vulnerable to symptoms of depression and/or anxiety.
However, association does not hold for nondairy calcium intake
The study evaluated Paxlovid in both vaccinated and unvaccinated patients with COVID-19 at standard risk for progressing to severe disease.
Evaluation shows safety and effectiveness for the management of localized prostate cancer
SHR3680 plus ADT improved radiographic progression-free survival and overall survival, when compared with bicalutamide plus ADT.
No evidence of increase seen for short- to medium-term cardiovascular risk, but data lacking regarding long-term safety
Estimated $100 million needed annually for the next 10 to 15 years to conduct epidemiological, biological research
Subvariants now account for 13% of new coronavirus cases nationwide compared with 7.5% a few weeks ago.
Among patients receiving radiation therapy (RT) for prostate cancer, intensity-modulated radiation therapy is significantly associated with a reduced risk for second primary solid malignancies compared with 3D conformal RT.
Compared with placebo, normalization of C-reactive protein and oxygen saturation faster, with improvements seen on day 3 of treatment
Load More
Open
Next post in Men's Health Update
Close
Close more info about Mixed Results for Paxlovid in Standard Risk Patients With COVID-19
Loading...
Close more info about Mixed Results for Paxlovid in Standard Risk Patients With COVID-19
Loading...